baber/WOPTO huggingface dataset:
Patent NZ-336120-A (NZ)
Title: process for preparing a cocoa liquor substitute by mixing an unroasted cocoa powder and a confectionery fat and then roasting the mixture
Inventor: MANEZ ANGEL
IPC: A23G1/38
Filed: 1999-06-03
Abstract: The process for producing compound liquor suitable for making compound coatings and alternatives to chocolate comprises mixing a cocoa powder which has been obtained from cocoa beans without any roasting treatment with a confectionery fat and roasting the mixture of the cocoa powder and confectionery fat to produce the compound liquor is claimed.
Patent NZ-337683-A (NZ)
Title: Methods for producing apomictic plants
Inventor: CARMAN JOHN G
IPC: A01H1/00
Filed: 1999-02-05
Abstract: A method for producing plants that genetically clone themselves (or gametophytic apomicts) is disclosed. The method involves hybridizing two sexual plant lines either from the same species or related species that have different start times and duration of female developmental stage in response to photoperiod, and relative to the development of nongametophytic ovule and ovary tissues. Once hybridized, lines with asynchronous flower development, and hence apomixis, are created.
Patent NZ-501836-A (NZ)
Title: Retentate chromatography and protein chip arrays with applications in biology and medicine
Inventor: HUTCHENS T WILLIAM
IPC: G06F19/00
Filed: 1998-06-19
Abstract: Methods of retentate chromatography for resolving analytes in a sample are provided. The methods involve adsorbing the analytes to a substrate under a plurality of different selectively conditions, and detecting the analytes retained on the substrate by desorption spectrometry. The methods are useful in biology and medicine, including clinical diagnostics and drug discovery.
Patent NZ-509649-A (NZ)
Title: Refiner plate with chicanes that each extend obliquely form an outer end of an inner rib to an inner end of an outer rib to form a zig zag shape
Inventor: GINGRAS LUC
IPC: D21D1/30
Filed: 1998-08-19
Abstract: A  refiner  plate  for the  face  of  a  refiner  disc comprising  a  plurality of refiner segments  (10)  arranged side-by-side   on  the  face  of  the   disc   to   form   a substantially annular refining region. Each refiner  segment has  a  plurality bars (32, 34), chicanes (46)  and  grooves (36,  38)  for  refining  a  lignocellulosic  material   and forming a zig-zag path for receiving and transmitting  steam generated  during the refining process. The chicanes  define a  series of substantially arcuate lines (56) extending from a  position  intermediate  the junction  of  the  inlet  and refining  zones  to the outer edge of the refiner  plate  in the counter-rotation direction.
Patent NZ-512605-A (NZ)
Title: New 1,1- and 1,2-disubstituted cyclopropane compounds, a process for their preparation and pharmaceutical compositions containing them
Inventor: CHARTON YVES
IPC: C07D213/65
Filed: 2001-06-26
Abstract: Compounds of formula (I) wherein: p , n is an integer of 0 to 6; R1 and R2 are independently hydrogen, linear or branched (C1-C6)alkyl, aryl, aryl(C1-C6)alkyl in which the alkyl moiety is linear or branched, or R1+R2 form together with the N a saturated 3- to 10-membered monocyclic or bicyclic system optionally containing a second hetero atom selected from O, N and S; X is selected from O, S, -CH=CH-, methylene, -HC=N-O-, and -O-CH2-CH=CH-, in which groups the O is linked to the Y moiety; Y is selected from aryl, heteroaryl, aryl(C1-C6)alkyl in which the alkyl moiety is linear or branched, -C(O)-A and -C(S)-A; A is selected from linear or branched (C1-C6)alkyl, aryl, heteroaryl, aryl(C1-C6)alkyl in which the alkyl moiety is linear or branched, heteroaryl(C1-C6)alkyl in which the alkyl moiety is linear or branched, and NR3R4 wherein R3 and R4 each are selected from hydrogen, linear or branched (C1-C6)alkyl , aryl, aryl(C1-C6)alkyl in which the alkyl moiety is linear or branched, or R3+R4 form together with the N atom a monocyclic or bicyclic (C3-C10) system; with the proviso that: a)  in the case of 1,1-disubstituted compounds of formula (1); p is other than 0 when X is a methylene, n is 0, Y is and aryl or heteroaryl, and R1 and R2 are independently hydrogen, linear or branched (C1-C4)alkyl, benzyl, phenylethyl, or form together with the N a morpholino, thiomorpholino or a 5- to 7-membered saturated carbocyclic system, p is other than 0 when X is methylene, n is 0, y is acetyl, and R1 and R2 are independently hydrogen linear or branched (C1-C4)alkyl, phenyl, benzyl, or form together with the N a piperidyl or morpholino group, R1 and R2 do not simultaneously represent a methyl group: *either when p and n each are 1, X is an O and Y is selected from p-nitrobenzoyl, p-aminobenzoyl, p-chlorophenylaminocarbonyl, and acetyl, *or when p is 0, nis 1, X is O or S and Y is a 2-quinolyl substituted in the 3-position by a linear or branched (C3-C4)alkyl, or a phenyl group, Y does not represent a 1,2-benzisoxazol-3-yl when n is 1, p is 0 and X is O; b)  in the case of 1,2-disubstituted compounds of formula (I); R1 and R2 do not simultaneously represent hydrogen when p and n are 0 and X-Y together represent a phenoxy group (optionally substituted by one or two identical groups selected from methoxy, dimethylamino, halogen, methyl, trifluoromethyl, nitro and amino), aphenylsulphanyl, benzyloxy, benzyl group or a 2-phenylethyl group, R1 and R2 do not simultaneously represent a methyl when p and n are each 0 and X-Y together represent a phenoxy group (optionally substituted by a chlorine or trifluoromethyl), a phenylsulphanyl or benzyl group. These compounds are useful in the treatment of neuropathologies associated with cerebral ageing, mood disorders, pain and tobacco withdrawal due to their specific interaction with central nicotinic receptors of type a4b2.
Patent NZ-521137-A (NZ)
Title: Novel fatty acid analogues
Inventor: BERGE ROLF
IPC: C07C323/52
Filed: 2001-03-02
Abstract: Described are fatty acid analogues of the formula R1- [xi - CH2]n - COOR2, wherein: R1 is alkene with one or more double bonds and one or more triple bonds, and/or an alkyne, and/or alkyl substituted in one or several positions with one or more compounds selected from fluoride, chloride, hydroxy, alkoxy, alkylthio, acyloxy and alkly, n is an integer from 1 to 12, i is an odd number and indicates the position relative to COOR2, and Xi independently of one another are selected from O, S, SO, SO2, Se and CH2. The analogues are used in the preparation of medicaments for the treatment of conditions such as Syndrome X, obesity, hypertension, fatty liver, diabetes, hyperglycaemia, hyperinsulinemia and stenosis.
Patent NZ-521380-A (NZ)
Title: Cellular telephone interactive wagering system
Inventor: MARSHALL CONNIE T
IPC: G06Q50/34
Filed: 2001-02-28
Abstract: A system for interactive wagering is provided using a cellular telephone to access an interactive wagering service. A user may view information on wagers such as current odds and other racing data for horses or other runners on the cellular telephone. The user may create a corresponding off-track wager with the cellular telephone that may be sent to a transaction processing and subscription management system. In example cellular telephone screen (68), menu items (84) are displayed for user to select. User selects the required option by moving and selecting a highlight region (82) with scroll keys. The transaction processing and subscription management system may handle the wager transaction and adjust the user's account balance.
Patent NZ-522419-A (NZ)
Title: Process for preparing a pharmaceutical composition comprising formoterol, a selective beta2 agonist, which has a high storage stability
Inventor: TROFAST EVA
IPC: A61P11/06
Filed: 2001-05-17
Abstract: Described is a stable pharmaceutical composition useful in the treatment of respiratory disorders such as asthma, rhinitis and chronic obstructive pulmonary disease (COPD).  Also described is a micronisation process for manufacturing a stable formulation of formoterol or its enantiomers and a carrier/diluent comprising a carbohydrate such as lactose.
Patent NZ-532397-A (NZ)
Title: Use of anti-glaucoma drugs to treat visual defects associated with the use of gabaergic agent
IPC: A61K45/00
Filed: 2004-04-20
Abstract: A method for treating visual field defects associated with the use of GABAergic drugs in a mammal. The method includes administering to the mammal an effective amount of a drug that improves retinal perfusion. In another embodiment, the invention provides a composition containing a GABAergic drug, and an effective amount of a drug that improves retinal perfusion. In an alternate embodiment, a method for treating visual field defects associated with use of a GABAergic drug in a mammal is provided that comprises administering an effective amount of erythropoietin. The invention also provides a composition comprising a GABAergic drug and an effective amount of erythropoietin.
Patent NZ-535369-A (NZ)
Title: Cross-linked bioactive hydrogel matrices
Inventor: LAMBERTI FRANCIS V
IPC: A61L27/52
Filed: 2003-02-21
Abstract: Described is a cross-linked bioactive hydrogel matrix that comprises a polyglycan, a peptide covalently cross-linked to the polyglycan and at least one agent that is selected from the group consisting of polar amino acids, amino acid analogues, amino acid derivatives, divalent cation chelators and combinations thereof. Also described are methods of preparing the cross-linked bioactive hydrogel matrix and methods for preparing bone implants comprising bioactive hydrogel matrix
Patent NZ-540340-A (NZ)
Title: 2-(1H-indazol-6-ylamino)-benzamide compounds as protein kinases inhibitors useful for the treatment of ophthalmic diseases
Inventor: BORCHARDT ALLEN JOHN
IPC: C07D401/14
Filed: 2003-12-08
Abstract: Indazole compounds that modulate and/or inhibit the ophthalmic diseases and the activity of certain protein kinases are disclosed. These compounds and pharmaceutical compositions containing them are capable of mediating tyrosine kinase signal transduction and thereby modulate and/or inhibit unwanted cell proliferation. The disclosure is also directed to the therapeutic or prophylactic use of pharmaceutical compositions containing such compounds. These indazole compounds are suitable for treating ophthalmic diseases and cancer and other disease states associated with unwanted angiogenesis and/or cellular proliferation, such as diabetic retinopathy, neovascular glaucoma, rheumatoid arthritis, and psoriasis.
Patent NZ-554254-A (NZ)
Title: Top down water heater
Inventor: ADAM QUENTIN ARTHUR CARL
IPC: F24D17/00
Filed: 2005-10-06
Abstract: A method of providing on-demand hot water in a storage water heating system is disclosed, which includes providing a heated water circuit which conducts heated water to or near to the top of the storage tank without convection mixing. A storage hot water system for performing this method is also disclosed.
Patent NZ-556392-A (NZ)
Title: Axle lifting device for a vehicle
Inventor: HOCK HELMUT
IPC: B60G99/00
Filed: 2007-01-11
Abstract: Disclosed is an axle raising device for a vehicle, in particular for pneumatic-suspension vehicle axes, which comprises of a support element (2), a lifting element (4), and a lever element (6). The support element and the lever element can be coupled to one another by means of the lifting element in such a way that, when the lifting element is actuated, the support element is supported on a frame element (16) of the vehicle, and the lever element exerts a preferably vertical force on an axle link of the vehicle in order to raise the vehicle. The lever element is positionally fixed in relation to a distal end of the axle link and/or the frame element. The support element is rotatably or pivotably mounted on the lever element.
Patent NZ-561616-A (NZ)
Title: Safety connector assembly for preventing inadvertant connection of tubing or other conduits
Inventor: HANLON JAMES G
Filed: 2007-09-18
Abstract: A connector assembly (30) for preventing sealing connection with a non-permitted, substantially uniform internal diameter conduit having an end face is disclosed. The connector assembly (30) comprises a first connector (36) having a floor (46) and a coupling portion (42). The coupling portion (42) projects outward from the floor (46), the coupling portion (42) including a sealing surface (48) and a non-sealing surface (52), the non-sealing surface (52) being located closer to a free end (44) of the first connector (36) than the sealing surface (48), the non-sealing surface (52) being sized and shaped to hold the non-permitted conduit off of the sealing surface (48) and prevent sealing therewith though the action of the passages (58). A bleed passage (60) is located generally adjacent the floor (46) for bleeding fluid out of the connector assembly (30).
Patent NZ-561928-A (NZ)
Title: Nanoparticle - active ingredient conjugates joined by a linker molecule
Inventor: JORDAN ANDREAS
IPC: A61K9/14
Filed: 2006-04-12
Abstract: Disclosed is a nanoparticle with at least one therapeutically active substance bound to the nanoparticle, and a linker molecule, wherein the linker molecule binds the therapeutically active substance to the nanoparticle, and wherein the linker molecule contains a group which is thermolabile, electromagnetically labile, photolabile, acid-labile or may be intercalated or enzymatically cleaved and is selected from the list described in the specificaition. Also disclosed is the use of the nanoparticles described above for treating proliferative diseases, cancer, and bacterial infections, whereby an alternating magnetic field is applied to cause the release of the active substance.
Patent NZ-562252-A (NZ)
Title: Monitoring subsurface temperature using a fiber optic cable coupled to a laser
Inventor: MCKINZIE BILLY JOHN
IPC: E21B47/06
Filed: 2006-04-21
Abstract: Disclosed is a system for monitoring temperature of a subsurface low temperature zone. The system comprises: a plurality of freeze wells (114) configured to form the low temperature zone; one or more lasers (142); a fiber optic cable (146) coupled to at least one laser; and an analyzer (144) coupled to the fiber optic cable. A portion of the fiber optic cable is positioned in at least one freeze well, and at least one of the lasers is configured to transmit light pulses into a first end of the fiber optic cable. The analyzer receives return signals from the light pulses.
Patent NZ-567758-A (NZ)
Title: Methods of inducing terminal differentiation using suberoylanilide hydrozmic acid (SAHA)
Inventor: RICHON VICTORIA M
IPC: A61K38/12
Filed: 2003-03-04
Abstract: Disclosed is a use of suberoylanilide hydroxamic acid (SAHA) represented by the following structure or a pharmaceutically acceptable salt or hydrate thereof, for preparation of an oral medicament for treatment of cancer in a patient, with the proviso that non-Hodgkin's lymphoma, leukaemia, myelodysplastic syndrome, and cancers with leukocyte infiltration are excluded, and wherein the SAHA or the pharmaceutically acceptable salt or hydrate thereof is orally administered as a single therapeutically effective dose of up to 400 mg daily.
Patent NZ-576424-A (NZ)
Title: Treatment of demyelinating disorders with soluble lymphotoxin-beta-receptor
Inventor: BROWNING JEFFREY
IPC: A61K38/17
Filed: 2007-10-18
Abstract: Disclosed is the use of a soluble Lymphotoxin-beta-Receptor (LTbetaR) and a pharmaceutically acceptable carrier in the manufacture of a medicament for promoting remyelination in a human subject having a demyelinating disorder, wherein said medicament is formulated for administration to the subject and in which remyelination in the subject is to be monitored
Patent NZ-577387-A (NZ)
Title: Indole derivatives as s1p1 receptor agonists
Inventor: AHMED MAHMOOD
IPC: A61P37/00
Filed: 2007-12-19
Abstract: Disclosed are indole-indolizine derivatives represented by general formula (I) or pharmaceutically acceptable salts thereof. Examples of such compounds include ethyl 3-[4-(5-{ 5-chloro-6-[(1-methylethyl)oxy]-3-pyridinyl} -1,2,4-oxadiazol-3-yl)-1H-indole-1-yl]propanoate. Also disclosed is the use of the compounds for treating diseases mediated by S1P1 receptors such as multiple sclerosis, autoimmune diseases, chronic inflammatory disorders, asthma, inflammatory neuropathies, arthritis, transplantation, Crohn's disease, ulcerative colitis, lupus erythematosis, psoriasis, ischemia-reperfusion injury, solid tumours, and tumour metastasis, diseases associated with angiogenesis, vascular diseases, pain conditions, acute viral diseases, inflammatory bowel conditions, insulin and noninsulin dependent diabetes.
Patent NZ-580904-A (NZ)
Title: Amino-heterocyclic compounds for inhibiting pde9
Inventor: VERHOEST PATRICK ROBERT
IPC: C07D487/04
Filed: 2008-05-05
Abstract: Disclosed are amino-heterocyclic compounds represented by the compounds of general formula (I), or pharmaceutically acceptable salts thereof, such as 6-[(3S,4S)1-benzyl-4-methylpyrrolid in-3-yl]-1-cyclopentyl-1,5-di hydro-4H-pyrazolo[3,4-d]pyrimidin-4-one. Also disclosed is the use of the compounds of formula (I) for inhibiting PDE9 and treating a neurodegenerative disease such as Alzheimer's disease.
Patent NZ-584099-A (NZ)
Title: Narrow neck glass container with internal embossments and method of manufacture
Inventor: MONDEN STEFAN
IPC: C03B9/193
Filed: 2008-09-25
Abstract: A method is disclosed of making a narrow neck glass container in a press-and-blow manufacturing operation. The container made includes a container body (38) with at least one internal embossment (20b, 24b). The method includes the steps of: (a) Providing a blank mold with a mould body and a neck ring. The neck ring has an internal surface for forming a container neck finish (34) with an external closure attachment diameter less than 36mm. The mould body has an internal surface with at least one debossment of a predetermined geometry. (b) Placing a gob of molten glass in the blank mould. (c) Moving a plunger through the neck ring into to form the molten glass gob against the internal surfaces of the blank mould to form a glass parison (26). The glass parison has a container neck finish (34) and a body with at least one external embossment (20a, 24a) corresponding to the mould body debossment. (d) Removing the glass parison from the mould. (e) Placing the glass parison into a blow mould (36). (f) Removing the narrow neck glass container (39) from the blow mould. After said step (c) but before said step (f) a blow gas is directed through the container neck finish (34) into the parison body (26) to stretch the parison body and push the external embossment (20a, 24a) through the parison body (26). The parison body stretches between 45% and 70% to form a stretched container with at least one internal embossment (20b, 24b) corresponding to the external embossment (20a, 24a).
Patent NZ-588118-A (NZ)
Title: Separator for receiving a pressurized fluid containing at least one solid material and one liquid material
Inventor: ESPINASSE PHILIPPE
IPC: E21C45/00
Filed: 2009-03-20
Abstract: Disclosed is a separator comprising a pressurized vessel (62) and first and second tank (64A, 64B) for depressurizing a pressurized liquid flow rich in solid material produced in the vessel (92). It comprises a directional control valve (66) connecting the vessel and each depressurizing tank (64). The directional control valve is movable between a first configuration in which it directs the pressurized flow to the first tank and depressurizes the second tank, and a second configuration in which it directs the pressurized flow to the second tank and depressurizes the first tank.
Patent NZ-591702-A (NZ)
Title: Test tape unit and test tape device
Inventor: LORENZ ROBERT
IPC: G01N35/04
Filed: 2009-10-14
Abstract: 591702 Disclosed is a test tape unit (10). The test tape unit (10) includes a flexible carrier tape (14) that can be wound forwards by a tape drive (16). A plurality of analytical test fields (32) for the application of body fluid are applied on the tape (14). Each test field (32) is located on an associated tape section along with a check field (50) that is separate from the test field (32). Each tape section has a plurality of position markers (48, 58) for different functional positions that are structured to each be individually identifiable as a measured quantity by means of a tape sensor (20). At least one position marker is a check position marker (48) assigned to the check field (50). The check position marker (48) is separate from the check field (50) and identifies a functional position at which the check field (50) can be scanned for a functional check by a measuring unit (18). The measuring unit (18) is also operable to measure the test field (32) when the tape section is in a different functional position.
Patent NZ-594138-A (NZ)
Title: Method for manufacturing a mixed solution comprising propionate and acetate
Inventor: KON ADRIAAN DIRK
IPC: A23L13/70
Filed: 2010-02-22
Abstract: 594138 Disclosed is a method for manufacturing a mixed solution comprising propionate and acetate, which comprises the steps of: a) providing a fermentation product comprising propionate, acetate, and carbonate-related compounds being carbonates, bicarbonates, and carbonic acids; and b) adding acid (such as lactic acid) to the fermentation product to obtain an acidified fermentation product comprising propionate and acetate with a pH in the range of 2.5 to below 8. Also disclosed is an aqueous solution obtained by the process as defined above, comprising lactate in an amount of 30-50 wt%, propionate in an amount of 0.5-7 wt%, and acetate in an amount of 0.5-7 wt%, for use as an additive or as a taste enhancer in food, meat (including uncured meat and poultry products) or drink products.
Patent NZ-609051-A (NZ)
Title: Combination tablet computer and game controller with bridge section
Inventor: DOOLEY DANIEL P
IPC: A63F13/23
Filed: 2013-04-11
Abstract: A device (240) for controlling a video game is disclosed comprising a tablet computer (242) and an electronic game controller input device (250) in electronic communication with the tablet computer (242). The input device (250) provides a pair of control modules (252) adjacent to and confining the tablet computer (242) on at least two sides. The pair of control modules (252) each provide input module apertures to secure an instructional input device such as a removable keyboard or game control module (Fig. 13). A structural bridge (258) secures the pair of control modules (252) together via fastening mechanism (264, 266) to confine the tablet computer (242).
Patent NZ-609542-A (NZ)
Title: Proportional dosimeter for metering an auxiliary liquid into a main liquid
Inventor: CHARRIERE CHRISTOPHE
IPC: F04B9/105
Filed: 2011-11-07
Abstract: 609542 Proportional dosimeter (D) for metering a liquid into a main fluid flow is disclosed. The dosimeter comprises a metering body with a main liquid inlet (2) and an outlet (3). A hydraulic motor (4) is housed in the body and actuated by the main liquid flow. The motor is connected to a plunger piston (5) that actuates a membrane (M) in second chamber (12). The second chamber (12) comprises an intake orifice (20) and a delivery orifice (23) for the auxiliary liquid. The delivery orifice (23) is connected by a pipe (26) to an injection chamber (S) situated downstream of the outlet (3) of the dosimeter body.
Patent NZ-611824-A (NZ)
Title: Improvements in and relating to load transfer
Inventor: KALVIN JIT SINGH
IPC: A01B59/042
Filed: 2013-06-11
Abstract: 611824 A unitary stationary member 3 of a load transfer structure 2 is mounted beneath a tractor and connected via a shock absorber 5 to a movable tow bar 4. The front of the member 3 is stepped-shaped at 13 to pass beneath the front axle 11 of the tractor and is connected via a mount 9 to the weight frame 10 on the tractor above the front axle.